DJIA 17,402.88 -275.82 -1.56%
NASDAQ 4,700.20 -71.57 -1.50%
S&P 500 2,034.04 -23.05 -1.12%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

32.98 -0.05 (-0.14%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $32.98 -0.14%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.67
Previous Close $33.02
Daily Range $32.57 - $33.27
52-Week Range $30.05 - $55.99
Market Cap $4.1B
P/E Ratio -63.50
Dividend (Yield) $0.00 (0.0%)
Volume 48,953
Average Daily Volume 1,414,472
Current FY EPS -$0.66





Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary

Why Seattle Genetics, Inc. Stock Dove 12% in December

Seattle Genetics' shares get hammered following impressive clinical data from its rivals at the American Society of Hematology's annual meeting. Find out whether this dip represents a buying opportunity or a red flag.

Earnings Peek: Market Seems Determined To Keep Seattle Genetics In The $30s

First Week of SGEN September 18th Options Trading

Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog

New Biotech ETF From ALPS

Bull of the Day: Incyte (INCY) - Bull of the Day

Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?

See More SGEN News...

SGEN's Top Competitors

SGEN $32.98 (-0.14%)
Current stock: SGEN
AMGN $159.06 (-0.42%)
Current stock: AMGN
GILD $106.21 (-0.84%)
Current stock: GILD
BIIB $362.87 (0.12%)
Current stock: BIIB